| Metric | H1 FY27 | H2 FY26 | H1 FY26 |
|---|---|---|---|
| Revenue from operations | 155.2 | 117.9 | 49.2 |
| Total income | 155.2 | 118.0 | 49.2 |
| Profit before exceptional items & tax | 9.0 | 9.6 | 0.4 |
| Profit before tax | 9.0 | 9.6 | 0.4 |
| Net profit | 9.0 | 9.2 | 0.3 |
| Operating margin | 5.8% | 8.1% | 0.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +2900.00% |
|---|---|
| Net profit, quarter on quarter | -2.20% |
| Revenue, year on year | +215.40% |
BSE results filing, BSE: 543848. Figures extracted from the filing.
Dev Labtech Venture Ltd: key numbers
- Share price
- ₹26.13
- Market cap
- ₹124.0 Cr
- Revenue (annual)
- ₹167.2 Cr
- Net profit (annual)
- ₹9.57 Cr
- P/E (TTM)
- 13.0×Sector 47.2×
- Promoter holding
- 56.69%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dev Labtech Venture Ltd
All →Dev Labtech Venture Convertible Warrants
Dev Labtech Venture approved issuance of up to 1.37 crore convertible warrants at Rs.13 each to promoters and non-promoters on preferential basis. The issue aggregates Rs.17.81 Crore for cash.
- Value
- ₹17.81 Cr
Dev Labtech Venture Capital Structure Change
Dev Labtech's shareholders approved raising authorised share capital from ₹25 Crore to ₹31 Crore at an EGM on 5 November 2026. The Memorandum capital clause is amended.
Dev Labtech Venture Convertible Warrants
Dev Labtech Venture's EGM passed an authorised capital increase and a convertible warrant issue, both with 100% votes in favour. Promoters did not vote on the warrants.
Dev Labtech Venture Annual General Meeting
Dev Labtech Venture held an EGM on 5 November 2026 and filed voting results. Resolution 2, approving convertible warrants on a preferential basis, passed with 100% votes in favour.
Dev Labtech Venture Convertible Warrants
Dev Labtech Venture's EGM considered an authorised capital increase and preferential convertible warrants. Voting results follow later; no issue amount or price is stated.
Dev Labtech Venture Board Meeting Date
Dev Labtech Venture schedules a board meeting on 6 November 2026 to approve half-year standalone and consolidated results. The trading window stays closed until 48 hours after results are declared.